Onward Medical N.V. (ONWRF)
OTCMKTS
· Delayed Price · Currency is USD
4.430
-0.320 (-6.74%)
At close: Apr 11, 2025
Onward Medical Statistics
Total Valuation
Onward Medical has a market cap or net worth of 212.24 million. The enterprise value is 195.51 million.
Market Cap | 212.24M |
Enterprise Value | 195.51M |
Important Dates
The next estimated earnings date is Tuesday, June 17, 2025.
Earnings Date | Jun 17, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 26.28M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 120.59 |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -5.29 |
EV / Sales | 101.37 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -38.78 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 17,778 |
Profits Per Employee | -373,337 |
Employee Count | 99 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.01% in the last 52 weeks. The beta is 0.86, so Onward Medical's price volatility has been lower than the market average.
Beta (5Y) | 0.86 |
52-Week Price Change | -19.01% |
50-Day Moving Average | 5.63 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 39.13 |
Average Volume (20 Days) | 624 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Onward Medical had revenue of 1.76 million and -36.96 million in losses.
Revenue | 1.76M |
Gross Profit | -36.13M |
Operating Income | -36.13M |
Pretax Income | -36.96M |
Net Income | -36.96M |
EBITDA | -35.90M |
EBIT | -36.13M |
Earnings Per Share (EPS) | n/a |
Balance Sheet
Cash & Cash Equivalents | n/a |
Total Debt | n/a |
Net Cash | n/a |
Net Cash Per Share | n/a |
Equity (Book Value) | n/a |
Book Value Per Share | n/a |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | -2,052.94% |
Pretax Margin | -2,100.00% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Onward Medical does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -17.41% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |